Health
Boosting the Brain’s Mitochondria to Try to Halt Parkinson’s – Genetic Engineering & Biotechnology News
UK charity provides £1.2 million ($1.7 million) in funding to refine molecule to protect dopamine-producing brain cells and slow down disease progression.
Parkinsons UK reports that it is investing up to £1.2 million into a one-year project in partnership with the University of Sheffield that aims to refine a molecule that could be developed into a drug to protect dopamine-producing brain cells and slow down the progression of Parkinson’s.
The funding boost comes via the charitys Parkinson’s Virtual Biotech initiative, which is fast-tracking the development of new treatments for people with Parkinsons. Scientists at the University of Sheffields Institute…
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours agoOne person dead after house fire in Melbourne’s south-east
-
Business12 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week